Zacks Research Issues Positive Forecast for PAHC Earnings

Key Points

• Zacks Research raised its Q3 2027 EPS estimate for Phibro Animal Health to $0.83 from $0.82 and maintains a “Strong-Buy” rating. Estimates call for $3.47 EPS in FY2027, rising to $3.88 by FY2029.
• Phibro’s latest quarterly results exceeded expectations, with EPS of $0.85 versus the $0.71 consensus and revenue of $396.75 million versus estimates of $381.18 million.
• The stock opened at $38.80, while analysts’ average rating is “Moderate Buy” with a $47.67 price target. The company also pays a $0.12 quarterly dividend, representing a 1.2% yield.

Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) - Stock analysts at Zacks Research upped their Q3 2027 EPS estimates for Phibro Animal Health in a report released on Friday, October 23rd. Zacks Research analyst Team now anticipates that the company will earn $0.83 per share for the quarter, up from their previous estimate of $0.82. Zacks Research currently has a "Strong-Buy" rating on the stock. The consensus estimate for Phibro Animal Health's current full-year earnings is $3.49 per share. Zacks Research also issued estimates for Phibro Animal Health's FY2027 earnings at $3.47 EPS, Q1 2028 earnings at $0.84 EPS, FY2028 earnings at $3.66 EPS and FY2029 earnings at $3.88 EPS.

Separately, Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Phibro Animal Health in a report on Friday, September 11th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $47.67.

Phibro Animal Health Price Performance

Phibro Animal Health stock opened at $38.80 on Monday. Phibro Animal Health has a 12 month low of $28.25 and a 12 month high of $60.08. The company has a current ratio of 2.96, a quick ratio of 1.27 and a debt-to-equity ratio of 1.84. The business's 50 day simple moving average is $36.70 and its 200 day simple moving average is $37.83. The company has a market cap of $1.58 billion, a price-to-earnings ratio of 15.90 and a beta of 0.42.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The company reported $0.85 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.14. The firm had revenue of $396.75 million during the quarter, compared to analyst estimates of $381.18 million. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS.

Institutional Trading of Phibro Animal Health

Hedge funds have recently bought and sold shares of the company. Sterling Capital Management LLC boosted its holdings in shares of Phibro Animal Health by 864.9% during the third quarter. Sterling Capital Management LLC now owns 714 shares of the company's stock worth $26,000 after purchasing an additional 640 shares during the period. KBC Group NV bought a new stake in shares of Phibro Animal Health in the first quarter worth about $29,000. Inspire Investing LLC increased its holdings in Phibro Animal Health by 84.9% during the 3rd quarter. Inspire Investing LLC now owns 4,219 shares of the company's stock valued at $151,000 after purchasing an additional 1,937 shares during the period. James Investment Research Inc. purchased a new position in Phibro Animal Health during the 3rd quarter valued at about $224,000. Finally, Sanctuary Advisors LLC purchased a new position in Phibro Animal Health during the 1st quarter valued at about $247,000. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 2nd were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, September 2nd. This represents a $0.48 annualized dividend and a yield of 1.2%. Phibro Animal Health's payout ratio is 19.67%.

About Phibro Animal Health

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company's products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.